HPMPA prodrugs (TSRL)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameHPMPA prodrugs (TSRL)
Drug Alias Name(L)-Tyr-NH-C16H33-HPMPA(L)-Tyr-NH-i-Bu cHPMPA(L)-Tyr-NH-C12H25-HPMPAUSC-150USC-089 +[9] 
ClassificationSmall molecules
Mechanisms of ActionVirus replication inhibitors
TargetsUpdating
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Multidrug-Resistant InfectionCytomegalovirus Infections +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTherapeutic Systems Research Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesTherapeutic Systems Research LaboratoriesUniversity Of Southern California
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Multidrug-Resistant InfectionCytomegalovirus Infections +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A